Relay Therapeutics, Inc. (RLAY)
18.87
-0.02
(-0.11%)
USD |
NASDAQ |
Sep 11, 16:00
18.86
-0.01
(-0.05%)
After-Hours: 20:00
Relay Therapeutics Price to Book Value : 4.633 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 4.633 |
| September 10, 2026 | 4.638 |
| September 09, 2026 | 4.582 |
| September 08, 2026 | 4.692 |
| September 04, 2026 | 4.675 |
| September 03, 2026 | 4.668 |
| September 02, 2026 | 4.545 |
| September 01, 2026 | 4.54 |
| August 31, 2026 | 4.513 |
| August 28, 2026 | 4.609 |
| August 27, 2026 | 4.768 |
| August 26, 2026 | 4.778 |
| August 25, 2026 | 5.051 |
| August 24, 2026 | 4.852 |
| August 21, 2026 | 4.773 |
| August 20, 2026 | 4.837 |
| August 19, 2026 | 5.092 |
| August 18, 2026 | 5.060 |
| August 17, 2026 | 5.075 |
| August 14, 2026 | 4.876 |
| August 13, 2026 | 4.894 |
| August 12, 2026 | 4.928 |
| August 11, 2026 | 4.908 |
| August 10, 2026 | 4.896 |
| August 07, 2026 | 4.854 |
| Date | Value |
|---|---|
| August 06, 2026 | 4.849 |
| August 05, 2026 | 4.835 |
| August 04, 2026 | 4.798 |
| August 03, 2026 | 4.611 |
| July 31, 2026 | 4.624 |
| July 30, 2026 | 4.776 |
| July 29, 2026 | 4.510 |
| July 28, 2026 | 4.491 |
| July 27, 2026 | 4.577 |
| July 24, 2026 | 4.528 |
| July 23, 2026 | 4.687 |
| July 22, 2026 | 4.732 |
| July 21, 2026 | 4.739 |
| July 20, 2026 | 4.709 |
| July 17, 2026 | 4.889 |
| July 16, 2026 | 4.756 |
| July 15, 2026 | 4.790 |
| July 14, 2026 | 4.685 |
| July 13, 2026 | 4.599 |
| July 10, 2026 | 4.912 |
| July 09, 2026 | 5.095 |
| July 08, 2026 | 4.820 |
| July 07, 2026 | 4.847 |
| July 06, 2026 | 4.641 |
| July 02, 2026 | 4.579 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| TG Therapeutics, Inc. | 13.66 |
| Karyopharm Therapeutics, Inc. | -- |
| Krystal Biotech, Inc. | 7.556 |
| Akebia Therapeutics, Inc. | 10.34 |
Price to Book Value Related Metrics
| PS Ratio | 332.04 |
| Price | 18.87 |
| Earnings Yield | -8.30% |
| Market Cap | 4.124B |